Heterocyclic and heteroaryl compounds for treating Huntington's disease

The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.In particular, the present description relates to substituted bicyclic heterocyclic...

Full description

Saved in:
Bibliographic Details
Main Authors Zhang, Nanjing, Mazzotti, Anthony R, Kassick, Andrew J, Sydorenko, Nadiya, Chen, Guangming, Moon, Young-Choon, Babu, Suresh, Narasimhan, Jana, Woll, Matthew G, Karp, Gary Mitchell, Alam, Md Rauful, Turpoff, Anthony, Arnold, Michael A, Gerasyuto, Aleksey I, Yan, Wuming, Patel, Jigar, Bhattacharyya, Anuradha
Format Patent
LanguageEnglish
Published 02.01.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.In particular, the present description relates to substituted bicyclic heterocyclic and heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Bibliography:Application Number: US201917254660